학술논문

Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial
Document Type
Journal
Source
ADVANCES IN THERAPY; NOV 7 2020, 12p.
Subject
Language
English
ISSN
18658652